| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 63.97▼ | 63.62▲ | 63.47▲ | 101.51▼ | 103.36▼ |
| MA10 | 63.67▲ | 63.37▲ | 77.14▼ | 107.36▼ | 111.13▼ |
| MA20 | 63.60▲ | 79.59▼ | 94.30▼ | 109.78▼ | 121.53▼ |
| MA50 | 63.38▲ | 98.99▼ | 104.84▼ | 116.04▼ | 113.95▼ |
| MA100 | 73.60▼ | 105.67▼ | 108.99▼ | 124.57▼ | 113.74▼ |
| MA200 | 92.50▼ | 109.23▼ | 111.33▼ | 118.14▼ | 73.71▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.114▲ | -0.352▼ | -4.269▼ | -2.922▼ | -5.164▼ |
| RSI | 54.357▲ | 9.746▼ | 8.116▼ | 11.691▼ | 18.596▼ |
| STOCH | 79.614 | 36.263 | 2.022▼ | 19.963▼ | 15.321▼ |
| WILL %R | -46.070 | -96.680▼ | -96.863▼ | -96.974▼ | -97.841▼ |
| CCI | 68.119 | -31.789 | -65.499 | -466.667▼ | -299.766▼ |
| ▼ RSI | $DXCM RSI(14) Crossed Below 30 | Set Alert |
| ▼ MACD | $DXCM MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| ▼ GAP | $DXCM Open Gap Down %5 | Set Alert |
| ▼ GAP | $DXCM Open Gap Down %3 | Set Alert |
| ▼ GAP | $DXCM Open Gap Down %2 | Set Alert |
| ▼ BREAK | $DXCM Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $DXCM Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $DXCM Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $DXCM Price Breaks 10 Days Low | Set Alert |
|
Friday, July 26, 2024 02:03 PM
Wall Street's major indexes ended higher on Friday as investors flocked back to tech megacaps that had triggered broad sell-offs earlier in the week, and inflation data boosted optimism that the ...
|
|
Friday, July 26, 2024 12:55 PM
DexCom (NASDAQ:DXCM) shares plunged to the lowest level in more than four years on Friday after the medical device maker slashed its full-year revenue outlook along with its Q2 2024 financials, drawing downgrades on Wall Street.
|
|
Friday, July 26, 2024 08:59 AM
DexCom Inc (NASDAQ:DXCM) reported second-quarter sales of more than $1 billion. That’s up 15% year-over-year on a reported basis and 16% on an organic basis. The glucose monitoring device maker reported a second-quarter adjusted EPS of 43 cents.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/07/24 | 66.00 | 67.44 | 62.34 | 64.00 | 53,914,127 |
| 25/07/24 | 111.17 | 112.55 | 107.56 | 107.85 | 11,417,975 |
| 24/07/24 | 111.97 | 113.08 | 110.00 | 111.94 | 3,614,773 |
| 23/07/24 | 111.65 | 113.28 | 110.441 | 112.13 | 2,370,361 |
| 22/07/24 | 112.76 | 113.25 | 110.75 | 111.65 | 1,728,965 |
| 19/07/24 | 111.73 | 112.155 | 110.04 | 111.66 | 2,274,469 |
| 18/07/24 | 114.595 | 116.215 | 110.67 | 110.69 | 2,810,747 |
| 17/07/24 | 116.04 | 117.19 | 114.58 | 114.61 | 2,562,757 |
| 16/07/24 | 112.93 | 116.12 | 112.08 | 116.06 | 2,520,629 |
| 15/07/24 | 113.54 | 114.77 | 112.05 | 113.01 | 1,922,836 |
|
|
||||
|
|
||||
|
|